{"filing":{"accession_number":"0001654954-26-006789","cik":"0001131399","ticker":"GLAXF","company_name":"GSK plc","form":"6-K","filing_date":"2026-07-22","report_date":null,"primary_document":"a4747n.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426006789/a4747n.htm"},"events":[{"id":19426,"run_id":17485,"accession_number":"0001654954-26-006789","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"This 6-K announces FDA approval of Jideytro (zidesamtinib) for ROS1-positive NSCLC, GSK's first approved medicine in lung cancer. While the approval itself is a regulatory milestone and product launch event, it does not fit neatly into the discrete event categories (not an earnings release, M\u0026A completion, impairment, or litigation). The disclosure is material—it represents a significant regulatory achievement and commercial milestone for GSK's oncology portfolio expansion strategy, particularly following the recently completed Nuvalent acquisition referenced in the filing.","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-07-22","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":18511,"accession_number":"0001654954-26-006789","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This 6-K announces FDA approval of Jideytro (zidesamtinib) for ROS1-positive NSCLC, GSK's first approved medicine in lung cancer. While the approval itself is a regulatory milestone and product launch event, it does not fit neatly into the discrete event categories (not an earnings release, M\u0026A completion, impairment, or litigation). The disclosure is material—it represents a significant regulatory achievement and commercial milestone for GSK's oncology portfolio expansion strategy, particularly following the recently completed Nuvalent acquisition referenced in the filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-22T16:52:37.456174+00:00","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-07-22"}]}